| Mar 3, 2026 |
Mar 5, 2026 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
22.5
|
-5,272
|
-85.86%
|
✗
|
$152.3K |
| Mar 2, 2026 |
Mar 3, 2026 |
Goff Brian
|
CEO |
Sell |
37.5
|
-18,055
|
-3.70%
|
✓
|
$522.9K |
| Mar 2, 2026 |
Mar 3, 2026 |
Burns James William
|
Chief Legal Officer |
Sell |
38.8
|
-5,218
|
-3.19%
|
✓
|
$151.1K |
| Mar 2, 2026 |
Mar 3, 2026 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
46.3
|
-4,055
|
-1.86%
|
✓
|
$117.4K |
| Mar 2, 2026 |
Mar 3, 2026 |
Jones Cecilia
|
CFO |
Sell |
42.5
|
-5,035
|
-2.77%
|
✓
|
$145.8K |
| Mar 2, 2026 |
Mar 3, 2026 |
Milanova Tsveta
|
Chief Commercial Officer |
Sell |
38.8
|
-2,868
|
-3.45%
|
✓
|
$83.1K |
| Mar 2, 2026 |
Mar 3, 2026 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
26.3
|
-2,223
|
-14.62%
|
✓
|
$64.4K |
| Mar 1, 2026 |
Mar 3, 2026 |
Viswanadhan Krishnan
|
Chief Corp Dev & Strategy |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2026 |
Jan 7, 2026 |
Milanova Tsveta
|
Chief Commercial Officer |
Sell |
30.0
|
-2,872
|
-7.63%
|
✓
|
$77.6K |
| Dec 30, 2025 |
Jan 2, 2026 |
Burns James William
|
Chief Legal Officer |
Sell |
30.0
|
-2,932
|
-8.46%
|
✓
|
$79.4K |
| Dec 30, 2025 |
Jan 2, 2026 |
Goff Brian
|
CEO |
Sell |
32.5
|
-18,703
|
-6.27%
|
✓
|
$506.7K |
| Dec 30, 2025 |
Jan 2, 2026 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
38.8
|
-2,932
|
-4.33%
|
✓
|
$79.4K |
| Dec 30, 2025 |
Jan 2, 2026 |
Milanova Tsveta
|
Chief Commercial Officer |
Sell |
30.0
|
-2,932
|
-9.13%
|
✓
|
$79.4K |
| Dec 30, 2025 |
Jan 2, 2026 |
Jones Cecilia
|
CFO |
Sell |
33.8
|
-2,932
|
-7.27%
|
✓
|
$79.4K |
| Nov 12, 2025 |
Nov 14, 2025 |
Scadden David
|
Director |
Sell |
50.0
|
-200
|
-1.12%
|
✓
|
$8.8K |
| Nov 11, 2025 |
Nov 13, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
37.5
|
-2,454
|
-3.82%
|
✓
|
$107.4K |
| Oct 30, 2025 |
Nov 3, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
53.8
|
-200
|
-0.32%
|
✓
|
$8.8K |
| Oct 27, 2025 |
Oct 29, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
32.5
|
-3,302
|
-5.08%
|
✓
|
$145K |
| Oct 8, 2025 |
Oct 10, 2025 |
Scadden David
|
Director |
Sell |
50.0
|
-200
|
-1.12%
|
✓
|
$8.2K |
| Sep 30, 2025 |
Oct 2, 2025 |
Scadden David
|
Director |
Sell |
50.0
|
-200
|
-1.12%
|
✓
|
$8K |
| Sep 26, 2025 |
Sep 30, 2025 |
Jones Cecilia
|
CFO |
Sell |
28.8
|
-3,651
|
-9.73%
|
✓
|
$134.2K |
| Sep 5, 2025 |
Sep 9, 2025 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
20.0
|
-8,546
|
-90.78%
|
✗
|
$315.1K |
| Aug 27, 2025 |
Aug 29, 2025 |
Scadden David
|
Director |
Sell |
50.0
|
-200
|
-1.12%
|
✓
|
$8K |
| Aug 11, 2025 |
Aug 13, 2025 |
Ballal Rahul D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2025 |
Aug 13, 2025 |
Smith Cynthia
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 8, 2025 |
Aug 12, 2025 |
Goff Brian
|
CEO |
Sell |
26.3
|
-11,085
|
-8.23%
|
✓
|
$406.5K |
| Jul 10, 2025 |
Jul 15, 2025 |
Scadden David
|
Director |
Sell |
32.5
|
-1,400
|
-7.37%
|
✓
|
$56K |
| Jul 9, 2025 |
Jul 11, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
17.5
|
-11,914
|
-16.28%
|
✓
|
$452.6K |
| Jul 8, 2025 |
Jul 10, 2025 |
Backstrom Jay T.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 10, 2025 |
Backstrom Jay T.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2025 |
Jul 3, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
32.5
|
-4,091
|
-6.26%
|
✓
|
$139.8K |
| Jun 24, 2025 |
Jun 26, 2025 |
Burns James William
|
Chief Legal Officer |
Sell |
28.8
|
-2,799
|
-8.90%
|
✓
|
$93.9K |
| Jun 24, 2025 |
Jun 26, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
37.5
|
-2,909
|
-4.86%
|
✓
|
$97.6K |
| Jun 24, 2025 |
Jun 26, 2025 |
Jones Cecilia
|
CFO |
Sell |
32.5
|
-1,780
|
-5.59%
|
✓
|
$59.7K |
| Jun 24, 2025 |
Jun 26, 2025 |
Milanova Tsveta
|
Chief Commercial Officer |
Sell |
28.8
|
-2,770
|
-9.59%
|
✓
|
$92.9K |
| Jun 24, 2025 |
Jun 26, 2025 |
Goff Brian
|
CEO |
Sell |
26.3
|
-18,700
|
-7.92%
|
✓
|
$627.2K |
| Jun 20, 2025 |
Jun 23, 2025 |
Ballal Rahul D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
CAPELLO JEFFREY D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
Foster-Cheek Kaye I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
FOUSE JACQUALYN A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
Ho Maykin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
Owen Adams Catherine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
Scadden David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2025 |
Jun 23, 2025 |
Smith Cynthia
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2025 |
Jun 17, 2025 |
CAPELLO JEFFREY D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2025 |
Jun 17, 2025 |
Owen Adams Catherine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 8, 2025 |
Apr 10, 2025 |
FOUSE JACQUALYN A
|
Director |
Sell |
37.5
|
-7,497
|
-4.78%
|
✓
|
$194.2K |
| Mar 5, 2025 |
Mar 7, 2025 |
Viswanadhan Krishnan
|
Chief Corp Dev & Strategy |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 7, 2025 |
Viswanadhan Krishnan
|
Chief Corp Dev & Strategy |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2025 |
Mar 4, 2025 |
Burns James William
|
Chief Legal Officer |
Sell |
32.5
|
-4,005
|
-5.76%
|
✓
|
$142.3K |
| Mar 1, 2025 |
Mar 4, 2025 |
Jones Cecilia
|
CFO |
Sell |
37.5
|
-2,275
|
-4.55%
|
✓
|
$80.9K |
| Mar 1, 2025 |
Mar 4, 2025 |
Milanova Tsveta
|
Chief Commercial Officer |
Sell |
32.5
|
-1,681
|
-6.84%
|
✓
|
$59.7K |
| Mar 1, 2025 |
Mar 4, 2025 |
Goff Brian
|
CEO |
Sell |
30.0
|
-12,947
|
-6.87%
|
✓
|
$460.1K |
| Mar 1, 2025 |
Mar 4, 2025 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
41.3
|
-4,005
|
-2.59%
|
✓
|
$142.3K |
| Mar 1, 2025 |
Mar 4, 2025 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
32.5
|
-1,655
|
-6.67%
|
✓
|
$58.8K |
| Feb 1, 2025 |
Feb 5, 2025 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
10.0
|
-2,272
|
-29.47%
|
✓
|
$78.1K |
| Jan 3, 2025 |
Jan 7, 2025 |
Milanova Tsveta
|
Chief Commercial Officer |
Sell |
25.0
|
-2,804
|
-12.92%
|
✓
|
$90.2K |
| Dec 11, 2024 |
Dec 13, 2024 |
Scadden David
|
Director |
Sell |
50.0
|
-200
|
-1.28%
|
✓
|
$9.3K |
| Nov 8, 2024 |
Nov 13, 2024 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
26.3
|
-772
|
-48.71%
|
✗
|
$43.3K |
| Nov 7, 2024 |
Nov 12, 2024 |
Ballal Rahul D.
|
Director |
Sell |
5.0
|
-20,000
|
-28.67%
|
✓
|
$1.1M |
| Nov 7, 2024 |
Nov 12, 2024 |
Burns James William
|
Chief Legal Officer |
Sell |
5.0
|
-21,752
|
-58.08%
|
✓
|
$1.1M |
| Sep 26, 2024 |
Sep 30, 2024 |
Jones Cecilia
|
CFO |
Sell |
25.0
|
-2,542
|
-11.20%
|
✓
|
$124.6K |
| Aug 11, 2024 |
Aug 13, 2024 |
Ballal Rahul D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2024 |
Aug 13, 2024 |
Smith Cynthia
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 8, 2024 |
Aug 12, 2024 |
Goff Brian
|
CEO |
Sell |
22.5
|
-11,091
|
-12.34%
|
✓
|
$474.1K |
| Jul 1, 2024 |
Jul 3, 2024 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
28.8
|
-3,705
|
-7.81%
|
✓
|
$162.5K |
| Jun 20, 2024 |
Jun 24, 2024 |
FOUSE JACQUALYN A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Smith Cynthia
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
CAPELLO JEFFREY D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Ballal Rahul D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Foster-Cheek Kaye I
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Ho Maykin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Owen Catherine E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Schenkein David P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Scadden David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Foster-Cheek Kaye I
|
Director |
Neutral |
27.5
|
-3,564
|
-32.07%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
FOUSE JACQUALYN A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Schenkein David P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Ballal Rahul D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Smith Cynthia
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Ho Maykin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Scadden David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
Owen Catherine E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Jun 17, 2024 |
CAPELLO JEFFREY D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Goff Brian
|
CEO |
Sell |
17.5
|
-12,115
|
-15.28%
|
✓
|
$591.7K |
| Jun 3, 2024 |
Jun 5, 2024 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
22.5
|
-1,362
|
-47.19%
|
✗
|
$60.5K |
| Apr 8, 2024 |
Apr 10, 2024 |
FOUSE JACQUALYN A
|
Director |
Sell |
32.5
|
-7,791
|
-5.37%
|
✓
|
$214.6K |
| Mar 7, 2024 |
Mar 11, 2024 |
Foster-Cheek Kaye I
|
Director |
Sell |
26.3
|
-1,285
|
-14.26%
|
✗
|
$40.6K |
| Mar 5, 2024 |
Mar 7, 2024 |
Foster-Cheek Kaye I
|
Director |
Sell |
22.5
|
-4,715
|
-34.36%
|
✗
|
$150.9K |
| Mar 5, 2024 |
Mar 7, 2024 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
22.5
|
-1,913
|
-39.86%
|
✗
|
$60.7K |
| Mar 1, 2024 |
Mar 5, 2024 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
37.5
|
-2,642
|
-3.38%
|
✓
|
$86K |
| Mar 1, 2024 |
Mar 5, 2024 |
Jones Cecilia
|
CFO |
Sell |
41.3
|
-672
|
-4.33%
|
✓
|
$21.9K |
| Mar 1, 2024 |
Mar 5, 2024 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
28.8
|
-1,214
|
-12.94%
|
✓
|
$39.5K |
| Mar 1, 2024 |
Mar 5, 2024 |
Goff Brian
|
CEO |
Sell |
32.5
|
-4,156
|
-7.17%
|
✓
|
$135.4K |
| Mar 1, 2024 |
Mar 5, 2024 |
Burns James William
|
Chief Legal Officer |
Sell |
37.5
|
-2,642
|
-3.55%
|
✓
|
$86K |
| Mar 1, 2024 |
Mar 5, 2024 |
Milanova Tsveta
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2024 |
Feb 29, 2024 |
Schenkein David P
|
Director |
Sell |
17.5
|
-69,329
|
-10.43%
|
✗
|
$2.4M |
| Feb 23, 2024 |
Feb 27, 2024 |
Schenkein David P
|
Director |
Sell |
17.5
|
-68,142
|
-10.27%
|
✗
|
$2.3M |
| Feb 20, 2024 |
Feb 22, 2024 |
Washburn Theodore James Jr.
|
Principal Accounting Officer |
Sell |
26.3
|
-504
|
-15.53%
|
✗
|
$13.4K |
| Feb 12, 2024 |
Feb 14, 2024 |
Gheuens Sarah
|
Chief Medical Officer |
Sell |
48.8
|
-642
|
-1.88%
|
✓
|
$16.1K |